首页> 外文期刊>生物医学研究杂志(英文版) >Using SELDI-TOF-MS technology for screening serum markers of hepatic carcinoma in rats
【24h】

Using SELDI-TOF-MS technology for screening serum markers of hepatic carcinoma in rats

机译:使用SELDI-TOF-MS技术筛选大鼠肝癌血清标志物

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To identify potential serum markers of hepatic carcinoma in rats through Surface-Enhanced Laser Desorption Ionization-Time of Flight-Mass Spectrometry(SELDI-TOF-MS) Technology. Methods: A rat model of hepatic carcinoma was established. The serum samples of hepatic carcinoma and normal rats were analyzed via SELDI-TOF-MS Technology. The changes of the serum protein fingerprint patterns were observed between the experimental group of hepatic carcinoma and the controls. The analysis was conducted by statistical software-Biomarker Wizard. Results: Fifty-six protein peaks in the serums were found. Within m/z 0-20 000, the protein peaks of m/z 1158, 8 835 and 15 302 of hepatic carcinoma serums were obviously higher in the rat models compared with those in the controls(P < 0.01). Conclusion: Three peaks were considered as potential biomarkers according to the serum protein fingerprint patterns of the hepatic carcinoma group and the control group.
机译:目的:通过表面增强激光解吸电离飞行时间质谱(SELDI-TOF-MS)技术鉴定大鼠肝癌的潜在血清标志物。方法:建立肝癌大鼠模型。通过SELDI-TOF-MS技术分析肝癌和正常大鼠的血清样品。观察肝癌实验组与对照组血清蛋白指纹图谱的变化。通过统计软件-生物标志物向导进行分析。结果:在血清中发现了56个蛋白质峰。在m / z 0-20 000范围内,肝癌模型小鼠血清m / z 1158、8 835和15 302的蛋白峰明显高于对照组(P <0.01)。结论:根据肝癌组和对照组的血清蛋白指纹图谱,认为三个峰是潜在的生物标志物。

著录项

  • 来源
    《生物医学研究杂志(英文版)》 |2008年第5期|286-289|共4页
  • 作者单位

    Key Laboratory of Antibody Technique of Ministry of Health, Nanfing 210029,Jiangsu Province, China;

    Department of Pathology, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China;

    Key Laboratory of Antibody Technique of Ministry of Health, Nanfing 210029,Jiangsu Province, China;

    Department of General Surgery, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, Jiangsu Province, China;

    Key Laboratory of Antibody Technique of Ministry of Health, Nanfing 210029,Jiangsu Province, China;

    Key Laboratory of Antibody Technique of Ministry of Health, Nanfing 210029,Jiangsu Province, China;

    Department of Pathology, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China;

    Department of General Surgery, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, Jiangsu Province, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 肿瘤学;
  • 关键词

    hepatic carcinoma model; SEIDI-TOF-MS; serum marker;

    机译:肝癌模型;SEIDI-TOF-MS;血清标志物;
  • 入库时间 2022-08-19 03:48:03
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号